PET imaging with [89Zr]Df-KN035 was performed before and after EGFR-TKI gefitinib treatment to evaluate PD-L1 expression, observing that the high dose of gefitinib inhibited tumor growth and decreased the tumoral uptake of [89Zr]Df-KN035 [80]. The gene discussed is CD274; the disease is neoplasm.